eMedicine Specialties > Dermatology > Benign Neoplasms

Mastocytosis: Multimedia

Author: Daniel J Hogan, MD, Clinical Professor of Internal Medicine (Dermatology), NOVA Southeastern University; Investigator, Hill Top Research, Florida Research Center
Coauthor(s): Christin Martino, Louisiana State University School of Medicine-Shreveport
Contributor Information and Disclosures

Updated: Sep 11, 2009

Multimedia

Urticaria pigmentosa lesions on the face of a chi...
(Enlarge Image)
Media file 1: Urticaria pigmentosa lesions on the face of a child. Courtesy of Lee H. Grafton, MD.
[ CLOSE WINDOW ]
Urticaria pigmentosa lesions on the face of a chi...

Urticaria pigmentosa lesions on the face of a child. Courtesy of Lee H. Grafton, MD.

Urticaria pigmentosa lesions on the back of a chi...
(Enlarge Image)
Media file 2: Urticaria pigmentosa lesions on the back of a child. Courtesy of Lee H. Grafton, MD.
[ CLOSE WINDOW ]
Urticaria pigmentosa lesions on the back of a chi...

Urticaria pigmentosa lesions on the back of a child. Courtesy of Lee H. Grafton, MD.

Lesion on the scalp of an infant.
(Enlarge Image)
Media file 3: Lesion on the scalp of an infant.
[ CLOSE WINDOW ]
Lesion on the scalp of an infant.

Lesion on the scalp of an infant.

Lesion on the arm. Courtesy of Lee H. Grafton, MD.
(Enlarge Image)
Media file 4: Lesion on the arm. Courtesy of Lee H. Grafton, MD.
[ CLOSE WINDOW ]
Lesion on the arm. Courtesy of Lee H. Grafton, MD.

Lesion on the arm. Courtesy of Lee H. Grafton, MD.

Blistering lesion.
(Enlarge Image)
Media file 5: Blistering lesion.
[ CLOSE WINDOW ]
Blistering lesion.

Blistering lesion.

Hematoxylin and eosin stain revealing mast cells ...
(Enlarge Image)
Media file 6: Hematoxylin and eosin stain revealing mast cells in the papillary dermis.
[ CLOSE WINDOW ]
Hematoxylin and eosin stain revealing mast cells ...

Hematoxylin and eosin stain revealing mast cells in the papillary dermis.

Giemsa stain revealing mast cells.
(Enlarge Image)
Media file 7: Giemsa stain revealing mast cells.
[ CLOSE WINDOW ]
Giemsa stain revealing mast cells.

Giemsa stain revealing mast cells.

More on Mastocytosis

Overview: Mastocytosis
Differential Diagnoses & Workup: Mastocytosis
Treatment & Medication: Mastocytosis
Follow-up: Mastocytosis
Multimedia: Mastocytosis
References
[ CLOSE WINDOW ]

References

  1. Valent P. Diagnostic evaluation and classification of mastocytosis. Immunol Allergy Clin North Am. Aug 2006;26(3):515-34. [Medline].

  2. Patnaik MM, Rindos M, Kouides PA, Tefferi A, Pardanani A. Systemic mastocytosis: a concise clinical and laboratory review. Arch Pathol Lab Med. May 2007;131(5):784-91. [Medline].

  3. Horny HP, Sotlar K, Valent P. Mastocytosis: state of the art. Pathobiology. 2007;74(2):121-32. [Medline].

  4. Bussmann C, Hagemann T, Hanfland J, Haidl G, Bieber T, Novak N. Flushing and increase of serum tryptase after mechanical irritation of a solitary mastocytoma. Eur J Dermatol. Jul-Aug 2007;17(4):332-4. [Medline].

  5. Hartmann K, Artuc M, Baldus SE, et al. Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis. Am J Pathol. Sep 2003;163(3):819-26. [Medline].

  6. Noack F, Escribano L, Sotlar K, et al. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL. Leuk Lymphoma. Feb 2003;44(2):313-9. [Medline].

  7. Brockow K, Akin C, Huber M, Metcalfe DD. IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis. Clin Immunol. May 2005;115(2):216-23. [Medline].

  8. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. Feb 2008;63(2):226-32. [Medline].

  9. Stein JA, Kamino H, Walters RF, Pomeranz MK. Mastocytosis with urticaria pigmentosa and osteoporosis. Dermatol Online J. Oct 15 2008;14(10):2. [Medline].

  10. Xu X, Solky B, Elenitsas R, Cotsarelis G. Scarring alopecia associated with mastocytosis. J Cutan Pathol. Oct 2003;30(9):561-5. [Medline].

  11. Kirsch R, Geboes K, Shepherd NA, et al. Systemic mastocytosis involving the gastrointestinal tract: clinicopathologic and molecular study of five cases. Mod Pathol. Dec 2008;21(12):1508-16. [Medline].

  12. Lappe U, Aumann V, Mittler U, Gollnick H. Familial urticaria pigmentosa associated with thrombocytosis as the initial symptom of systemic mastocytosis and Down's syndrome. J Eur Acad Dermatol Venereol. Nov 2003;17(6):718-22. [Medline].

  13. Soilleux EJ, Brown VL, Bowling J. Cutaneous mastocytosis localized to a radiotherapy field. Clin Exp Dermatol. Jan 2009;34(1):111-2. [Medline].

  14. Soilleux EJ, Grills C, Cooper SM. Cutaneous mastocytosis in human immunodeficiency virus: an unfortunate coincidence?. Clin Exp Dermatol. Aug 2008;33(5):619-21. [Medline].

  15. Matsumoto M, Ikeda M, Takeya M, Kodama H. Plane xanthoma associated with multiple mastocytoma. Pediatr Dermatol. Sep-Oct 2007;24(5):E66-9. [Medline].

  16. Butterfield JH. Systemic mastocytosis: clinical manifestations and differential diagnosis. Immunol Allergy Clin North Am. Aug 2006;26(3):487-513. [Medline].

  17. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am. Aug 2006;26(3):451-63. [Medline].

  18. Heide R, Beishuizen A, De Groot H, et al. Mastocytosis in children: a protocol for management. Pediatr Dermatol. Jul-Aug 2008;25(4):493-500. [Medline].

  19. Van Gysel D, Oranje AP, Vermeiden I, de Lijster de Raadt J, Mulder PG, van Toorenenbergen AW. Value of urinary N-methylhistamine measurements in childhood mastocytosis. J Am Acad Dermatol. Oct 1996;35(4):556-8. [Medline].

  20. Jordon RE. Immunologic Diseases of the Skin. East Norwalk, Conn: Appleton & Lange; 1991:245-8.

  21. Verma KK, Bhat R, Singh MK. Bullous mastocytosis treated with oral betamethasone therapy. Indian J Pediatr. Mar 2004;71(3):261-3. [Medline].

  22. Kinsler VA, Hawk JL, Atherton DJ. Diffuse cutaneous mastocytosis treated with psoralen photochemotherapy: case report and review of the literature. Br J Dermatol. Jan 2005;152(1):179-80. [Medline].

  23. Gobello T, Mazzanti C, Sordi D, et al. Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study. J Am Acad Dermatol. Oct 2003;49(4):679-84. [Medline].

  24. [Guideline] Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. Mar 2005;115(3 Suppl 2):S483-523. [Medline].

  25. Wilson TM, Metcalfe DD, Robyn J. Treatment of systemic mastocytosis. Immunol Allergy Clin North Am. Aug 2006;26(3):549-73. [Medline].

  26. Krishnan K, Ramu V, Krishnaswamy G, Vardhana H. Mastocytosis, Systemic. eMedicine from WebMD [serial online]. December 4, 2008;Available at http://emedicine.medscape.com/article/203948-overview.

  27. Hoffmann KM, Moser A, Lohse P, et al. Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation. Blood. Sep 1 2008;112(5):1655-7. [Medline].

  28. Siebenhaar F, Kuhn W, Zuberbier T, Maurer M. Successful treatment of cutaneous mastocytosis and Ménière disease with anti-IgE therapy. J Allergy Clin Immunol. Jul 2007;120(1):213-5. [Medline].

  29. Ellis DL. Treatment of telangiectasia macularis eruptiva perstans with the 585-nm flashlamp-pumped dye laser. Dermatol Surg. Jan 1996;22(1):33-7. [Medline].

  30. Resh B, Jones E, Glaser DA. The cosmetic treatment of urticaria pigmentosa with Nd:YAG laser at 532 nanometers. J Cosmet Dermatol. Jun 2005;4(2):78-82. [Medline].

  31. Vlieg-Boerstra BJ, van der Heide S, Oude Elberink JN, Kluin-Nelemans JC, Dubois AE. Mastocytosis and adverse reactions to biogenic amines and histamine-releasing foods: what is the evidence?. Neth J Med. Jul-Aug 2005;63(7):244-9. [Medline].

  32. Allison MA, Schmidt CP. Reactivated urticaria pigmentosa. Cutis. Jul 1998;62(1):47-8. [Medline].

  33. Braverman IM. Skin Signs of Systemic Disease. 3rd ed. Philadelphia, Pa: WB Saunders; 1998:341-3.

  34. Brockow K, Scott LM, Worobec AS, et al. Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease. Arch Dermatol. Jun 2002;138(6):785-90. [Medline].

  35. Eichenfield LF, Honig PJ. Blistering disorders in childhood. Pediatr Clin North Am. Aug 1991;38(4):959-76. [Medline].

  36. Emanuel PD, Barton JC, Gualtieri RJ, Sams WM Jr. Urticaria pigmentosa and preleukemia: evidence for reactive mast cell proliferation. J Am Acad Dermatol. May 1991;24(5 Pt 2):893-7. [Medline].

  37. Fitzpatrick TB, Johnson RA, Wolff K. Color Atlas and Synopsis of Clinical Dermatology. 3rd ed. New York, NY: McGraw-Hill; 1997:562-5.

  38. Freedberg IM, Eisen AZ, Wolff K, eds. Fitzpatrick's Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill; 1999:1902-8.

  39. Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 3rd ed. Philadelphia, Pa: Mosby; 1996:144-5.

  40. Hartmann K, Henz BM. Mastocytosis: recent advances in defining the disease. Br J Dermatol. Apr 2001;144(4):682-95. [Medline].

  41. Has C, Misery L, David L, Cambazard F. Recurring staphylococcal scalded skin syndrome-like bullous mastocytosis: the utility of cytodiagnosis and the rapid regression with steroids. Pediatr Dermatol. May-Jun 2002;19(3):220-3. [Medline].

  42. Kastrup EK. Drug Facts and Comparisons. St. Louis, Mo: Facts and Comparisons; 1998:1153-6, 1597-1600, 2057-67.

  43. Leaf FA, Jaecks EP, Rodriguez DR. Bullous urticaria pigmentosa. Cutis. Nov 1996;58(5):358-60. [Medline].

  44. Lever WF. Histopathology of the Skin. 8th ed. Philadelphia, Pa: Lippincott-Raven; 1997:141-3.

  45. Longley J, Duffy TP, Kohn S. The mast cell and mast cell disease. J Am Acad Dermatol. Apr 1995;32(4):545-61; quiz 562-4. [Medline].

  46. Roberts LJ 2nd, Sweetman BJ, Lewis RA, Austen KF, Oates JA. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med. Dec 11 1980;303(24):1400-4. [Medline].

  47. Schachner LA, Hansen RC. Pediatric Dermatology. 2nd ed. New York, NY: Churchill Livingstone; 1995:852-8.

  48. Soter NA. The skin in mastocytosis. J Invest Dermatol. Mar 1991;96(3):32S-38S; discussion 38S-39S. [Medline].

  49. van Toorenenbergen AW, Oranje AP. Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis. Clin Chim Acta. Sep 2005;359(1-2):72-7. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

mastocytosis, mastocytoma, telangiectasia macularis eruptiva perstans, TMEP, urticaria pigmentosa, mast cell proliferation

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Daniel J Hogan, MD, Clinical Professor of Internal Medicine (Dermatology), NOVA Southeastern University; Investigator, Hill Top Research, Florida Research Center
Daniel J Hogan, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Contact Dermatitis Society, and Canadian Dermatology Association
Disclosure: Nothing to disclose.

Coauthor(s)

Christin Martino, Louisiana State University School of Medicine-Shreveport
Christin Martino is a member of the following medical societies: American Medical Association and Student National Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Timothy McCalmont, MD, Director, UCSF Dermatopathology Service, Professor of Clinical Pathology and Dermatology, Departments of Pathology and Dermatology, University of California at San Francisco
Timothy McCalmont, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, American Society of Dermatopathology, California Medical Association, College of American Pathologists, and United States and Canadian Academy of Pathology
Disclosure: Apsara Consulting fee Independent contractor

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Rosalie Elenitsas, MD, Herman Beerman Associate Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System
Rosalie Elenitsas, MD is a member of the following medical societies: American Academy of Dermatology and American Society of Dermatopathology
Disclosure: Nothing to disclose.

CME Editor

Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology
Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds None; Genentech Consulting fee Consulting; Centocor Consulting fee Consulting; Centocor Grant/research funds None; Covance Consulting fee Consulting; Shire  Consulting

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.